Literature DB >> 8699126

Effects of released products from platelets on neutrophilic adhesion to endothelial cells and nylon fibers.

M Oryu1, H Sakamoto, Y Ogawa, S Tanaka, N Sakamoto.   

Abstract

In this study, the effects of platelet release products (PRPr), ATP, and ADP on the adhesion of human neutrophils to human umbilical vein endothelial cells (HUVEC) and nylon fibers (NF) are described and the implications of various adhesion molecules are considered. Adhesion of neutrophils to HUVEC and NF was increased by PRPr, ATP, and ADP, while their adhesion-increasing actions were cancelled or considerably repressed by apyrase treatment. When anti-CD11a or anti-CD11b was added to neutrophils with PRPr, ATP, or ADP, the adhesion-increasing action was cancelled or considerably repressed. On the other hand, anti-ICAM-1 and anti-CD35 had no significant effects on this action. The above results indicated that platelets, through ATP and ADP in PRPr, increased the adhesion of neutrophils to endothelial cells and foreign bodies. Although it was suggested that the adhesion-increasing action was at least partially based on CD11a and CD11b, ICAM-1 and CD35 had no part in the enhancement of the adhesion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699126     DOI: 10.1002/jlb.60.1.77

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  3 in total

1.  Regulation of innate immunity by extracellular nucleotides.

Authors:  Stefania Gorini; Lucia Gatta; Laura Pontecorvo; Laura Vitiello; Andrea la Sala
Journal:  Am J Blood Res       Date:  2013-01-17

Review 2.  P2 receptors: new potential players in atherosclerosis.

Authors:  Francesco Di Virgilio; Anna Solini
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

3.  Human neutrophils do not express purinergic P2X7 receptors.

Authors:  Guadalupe Martel-Gallegos; María T Rosales-Saavedra; Juan P Reyes; Griselda Casas-Pruneda; Carmen Toro-Castillo; Patricia Pérez-Cornejo; Jorge Arreola
Journal:  Purinergic Signal       Date:  2010-02-24       Impact factor: 3.765

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.